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Abstract
Next generation DNA sequencing (NGS) technologies have revolutionized the pace at which whole genome and exome
sequences can be generated. However, despite these advances, many of the methods for targeted resequencing, such as
the generation of high-depth exome sequences, are somewhat limited by the relatively large amounts of starting DNA that
are normally required. In the case of tumour analysis this is particularly pertinent as many tumour biopsies often return
submicrogram quantities of DNA, especially when tumours are microdissected prior to analysis. Here, we present a method
for exome capture and resequencing using as little as 50 ng of starting DNA. The sequencing libraries generated by this
minimal starting amount (MSA-Cap) method generate datasets that are comparable to standard amount (SA) whole exome
libraries that use three micrograms of starting DNA. This method, which can be performed in most laboratories using
commonly available reagents, has the potential to enhance large scale profiling efforts such as the resequencing of tumour
exomes.
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Introduction
The advent of massively parallel sequencing technologies has
enabled the rapid and cost effective resequencing of cancer
genomes and exomes [1,2,3]. However, despite the constant
improvement of NGS technologies, one limitation is the amount of
starting material that is often required. For example, standard
protocols for targeted resequencing of the human exome using
sequence capture [4] require, on average, one to three mg of
starting DNA. These sequence capture methods involve DNA
fragmentation, end repair and A-tailing of the fragmented DNA
followed by hybridization to RNA (in case of the Agilent
SureSelect system) or DNA baits (in case of the NimbleGen or
Illumina systems) that are designed to physically capture specific
DNA sequences. The captured DNA is then eluted from the baits,
purified using a biotin-based precipitation and then amplified by
PCR to yield enough material for sequencing. In the analysis of
many tissue biopsies, such as microdissected tumour material,
microgram amounts of DNA are often problematic to obtain.
Around 125 ng of genomic DNA is usually recovered from an 8
micron (m) thick microdissected tumour biopsy and therefore 30–
40 tumour sections are required to obtain sufficient DNA for deep
sequencing. With the increasing use of small core biopsies [5] and
the requirement to perform multiple types of analysis on a single
sample (e.g. genetic, genomic, transcriptomic, proteomic and
histological analysis), the limitations of DNA recovery from
biopsies are exacerbated.
Efforts have already been made to modify existing NGS sample
preparation methods so that they may be applied to submicro-
gram amounts of starting DNA. These have either focussed upon
using whole genome amplified (WGA) material [6], or exploiting
transposon-mediated sample preparation [7]. However, both of
these methods have significant drawbacks. WGA can result in
libraries with low complexity, the absence of some targeted
regions in the final sequenced library and can also be slightly
biased towards the capture of AT-rich sequences [6]. Similarly,
the use of transposon-coupled target systems with submicrogram
amounts of DNA results in sequencing libraries with much lower
complexity and capture specificity than microgram-based librar-
ies [7].
Because of these problems, we have developed a modification of
the commonly used Agilent SureSelect capture method that is able
to use as little as 50 ng of starting DNA. By benchmarking the
performance of sequencing libraries generated using this proce-
dure, Minimal Starting Amount Capture Method (MSA-Cap),
against widely accepted criteria (uniformity of coverage, library
complexity, capture specificity, etc.) we find that our exome
capture method generates high quality data that is comparable
with sequencing libraries generated using microgram amounts of
starting material. Moreover, MSA-Cap uses standard reagents and
PLoS ONE | www.plosone.org 1 March 2012 | Volume 7 | Issue 3 | e32617
can be easily implemented in any laboratory, giving it the potential
for widespread application.
Materials and Methods
DNA
The following genomic DNA samples were used for this study:
(i) Normal DNA derived from an immortalized cell line of a
Caucasian female. This sample is part of the HapMap
collection [8], number NA12813.
(ii) Peripheral blood DNA from a patient with plasma cell
leukaemia (abbreviated throughout the text as PCL-tumour,
,90% tumour cells). This sample harbours translocations
(t(11;14) and t(12;17)) and copy number changes (del(6q),
del(13q), del(12p), del(17p) and gain(6p)), identified using
GeneChip Mapping SNP 6.0 array.
(iii) Non-tumour, buccal swab DNA from the patient described
above (abbreviated PCL-buccal swab).
Ethics statement
Ethics approval for the use of these samples was obtained from
the Royal Marsden Hospital under CCR3019, REC 08/H0806/
98. Informed written consent was obtained from the patient.
Standard Exome library preparation
For the generation of standard exome capture libraries, we used
the Agilent SureSelect Target Enrichment protocol for Illumina
paired-end sequencing library (v. 2.0.1, May 2010) together with
3 mg input DNA. In all cases, the SureSelect Human All Exon
Version 1 (38Mb) probe set was used.
Minimal Starting Amount Capture (MSA-Cap) library
preparation
A step by step protocol for MSA-Cap is provided as Methods
S1. In brief, MSA-Cap was performed as follows (numbers for
each step refer to steps in Figure 1):
(1) Fragmentation
Fragmentation of 50 ng of genomic DNA (estimated using a
Qubit dsDNA High Sensitivity Assay) was performed using
adaptive focused acoustic technology (AFA; Covaris) in a reaction
volume of 75 ml (45 ml nuclease-free water plus 30 ml sample in
Qiagen elution buffer EB). The fragmentation conditions used
were: duty cycle 20%, intensity 5, cycle burst 200 and time
140 sec.
(2) Assessment of fragmentation quality
The efficiency of fragmentation was assessed using Bioanalyzer
High Sensitivity DNA assay.
(3) End-repair
After fragmentation, samples were end-repaired using the New
England Biolabs (NEB) sample preparation kit and protocol (NEB
Next DNA Sample prep, E6000S), with incubation time of
30 minutes. Following end-repair, samples were purified using
Zymo columns (DNA Clean&Concentrator kit-5, Zymo Research,
USA) and eluted in 33 ml EB, pre-heated to 50uC.
(4) A-tailing
After end-repair, a single dA was added to the 39 end of each
blunted, phosphorylated DNA template using Klenow Fragment
DNA Polymerase (39-.59 exo-) from the New England Biolabs
(NEB) sample preparation kit (using an incubation time of
30 minutes). At the end of the incubation, the samples were
purified with the DNA Clean&Concentrator kit-5 (Zymo Re-
search, USA) and eluted in 12 ml EB.
(5) Ligation
After A-tailing, DNA ligation was performed using the following
adapters (* indicating phosphorothioate bond):
Top adapter 59 ACACTCTTTCCCTACACGACGCTCTTCC-
GATC*T 39 and
Bottom adapter 59 GATCGGAAGAGCGGTTCAGCAGGAA-
TGCCGAG 39
Both oligonucleotides were HPLC purified and purchased from
Sigma. The volume of the adapters was calculated as described in
[9]. The ligation was conducted using the New England Biolabs
(NEB) sample preparation kit and with an incubation time of
25 minutes. The samples were cleaned using solid-phase reversible
immobilization (SPRI) magnetic beads and eluted in 96 ml
nuclease-free water. Ligation efficiency was evaluated using the
Bioanalyzer High Sensitivity DNA assay.
(6) Pre-hybridization PCR
Once ligation had been assessed, the adapter ligated library
was PCR amplified according to the following protocol: 92 ml of
the adapter-ligated sample was mixed with 100 ml of stock 26
Phusion HF master mix and 4 ml of stock 25 mM PCR primer
PE2.1 and 4 ml of stock 25 mM PCR primer PE2.2. The final
200 ml of sample was divided into four aliquots of 50 ml. Each was
subjected to the following cycling conditions: step 1, 98uC for
2 min; step 2, 98uC for 20 sec; step 3, 65uC for 30 sec; step 4,
72uC for 30 sec; step 5, 72uC for 5 min; with steps 2 to 4
repeated 8 times in total. The amplified samples were purified
using SPRI beads and eluted in 60 ml nuclease-free water. The
amount of amplified material was estimated using a Bioanalyzer
High Sensitivity assay.
The sequences of the PCR primers used above were as follows (*
indicating phosphorothioate bond):
PE 2.1
5 9 AATGATACGGCGACCACCGAGATCTACAC
TCTTTCCCTACACGACGCTCTTCCGATC*T 39
and PE 2.2
5 9 C A A G C A G A A G A C G G C A T A C G A G A T
CGGTCTCGGCATTCCTGCTGAACCGCTCTTCC-
GATC*T 39
Both oligonucleotides were HPLC-purified and purchased from
Sigma.
(7) Hybridization
From the purified sample, 250 ng of DNA was aliquoted into a
1.5-ml Eppendorf tube and then vacuum dried and resuspended in
3.4 ml nuclease-free water. Resuspended DNA was then mixed
with hybridization buffers, blocking mixes, RNase block and 5 ml
of SureSelect all exon capture library, according to the standard
Agilent SureSelect Target Enrichment protocol. Hybridization to
the exome capture baits was conducted at 65uC using heated
thermal cycler lid option at 105uC for 24 hours on a Bio-Rad
DNA Engine PCR machine.
Whole Exome Resequencing from Nanograms of DNA
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Figure 1. Flow chart comparing the standard Agilent Whole Exome Target Enrichment protocol (SA protocol, v. 2.0.1), and the
Minimal Starting Amount Capture (MSA-Cap) protocol.
doi:10.1371/journal.pone.0032617.g001
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(8) Isolation of exomic DNA
Targeted DNA from the exomic regions was recovered using
SureSelect magnetic beads (according to manufacturer’s instruc-
tions) , washed thoroughly, eluted, purified using the using DNA
Clean&Concentrator kit-5 and then collected in 15 ml nuclease-
free water.
(9) Post-hybridization PCR
The captured DNA was then amplified using the following
protocol: 15 ml of the sample was mixed with 22.5 ml of nuclease-
free water, 10 ml of 56Herculase II reaction buffer, 0.5 ml dNTP
mix, 1 ml Herculase II Phusion DNA polymerase and 1 ml
SureSelect GA PCR primers. This reaction mix was subjected to
the following cycling conditions: step 1, 98uC for 2 min; step 2,
98uC for 20 sec; step 3, 60uC for 30 sec; step 4, 72uC for 30 sec;
step 5, 72uC for 5 min; step 6, 4uC on hold; with steps 2 to 4
repeated 8 times in total. The amplified samples were purified
using SPRI beads and eluted in 60 ml nuclease-free water.
(10) Flowcell preparation
Each sample was diluted or concentrated to 1.0 nM molarity
and denatured following the standard Illumina protocol.
Sequencing
All samples were sequenced on an Illumina Genome Analyzer
IIX System, using 2676 bp reads. Each sequencing run yielded
,90% purity filtered clusters, providing 8–10 GB of raw yield per
sample (Table S1).
Data generation pipeline
Paired end short reads were generated with the Illumina OLB
1.8 and CASAVA 1.7 software pipelines using default param-
eters except for the removal of the first and last cycle from each
read. The first cycle read is removed as a photobleaching effect
on this cycle can often lead to an incorrect base call. The last
cycle read does not have phase correction, therefore is also prone
to errors in base call. Reads were further filtered to remove low
complexity regions (over 95% same base call) and reads with
over 5% N base calls. PCR duplicates were subsequently
removed, retaining only the top Phred scoring paired end short
read in each case.
All data were deposited in the Sequence Read Archive at the
European Molecular Biology Laboratory’s European Bioinfor-
matics Institute (EMBL-EBI). The study accession number is
ERP001066 (http://www.ebi.ac.uk/ena/data/view/ERP001066).
Alignment, detection of SNPs and indels and structural
variation study
The alignment of short reads to the human genome (hg19) was
performed using BWA [10] and variants assigned using the
Unified Genotyper within the Broad Institute Genome Analysis
Toolkit (GATK) version 1.0.5273 [11,12]. We used the Ensembl
human variation database version 56 and the Ensembl Perl API
system (http://www.ensembl.org/info/docs/api/index.html) to
assign candidate functions to variants.
SNP genotyping
We used the GeneChip Mapping SNP 6.0 array (Affymetrix,
High Wycombe, UK) to assign SNP genotypes, according to
manufacturer’s instructions. SNP genotypes and copy number
profiles were generated using GTYPE and dChip, as previously
described [13].
Copy number profiling by deep sequencing
Copy number profiling was performed as described in [14].
Results
A modified exome capture method
To facilitate targeted resequencing from minimal amounts of
starting DNA, we designed a method, Minimal Starting Amount
Capture (MSA-Cap), that is able to utilize as little as 50 ng starting
DNA (Figure 1, Methods S1). In general MSA-Cap uses the same
workflow as the Agilent SureSelect capture procedure (DNA
fragmentation, end-repair, A-tailing, TA-mediated adapter liga-
tion, PCR amplification, hybridization, post hybridization PCR
(Figure S1), but encapsulates critical modifications at a number of
steps (Figure 1). These modifications achieve three goals: (1) to
minimize loss of DNA material during washing steps, (2) to use as
much material as possible during PCR amplification steps, and (3)
to minimize the amount of library DNA required for hybridization
and flowcell preparation.
To minimise loss of DNA during washing steps we used the
following modifications:
(i) An optimised DNA shearing protocol that enabled 50 ng
DNA to be fragmented in 75 mL volume (Figure 1 step 1).
This optimised protocol abolished the requirement for DNA
to be concentrated after fragmentation, a step that can often
lead to loss of ,20% of material.
(ii) Where DNA purification steps were absolutely required, we
used the DNA Clean&Concentrator kit-5 containing Zymo
clean columns (Zymo Research, USA) rather than more
commonly used Qiagen columns or solid-phase reversible
immobilization (SPRI) magnetic beads (Figure 1 steps 3 to 4,
4 to 5 and 8 to 9). In general we found Zymo columns to
recover 27% more material than Qiagen columns (Figure
S2).
Our second goal was to use as much material as possible during
amplification. To achieve this, the following modifications were
made:
(i) At the adapter ligation step, we used a 20:1 molar ratio of
adapter: fragmented DNA instead of the more commonly
used 10:1 ratio (Figure 1, step 5). We reasoned that the use
of this ratio would result in a higher yield of adapter ligated
templates. In addition, the time course of the ligation
reaction was extended to 25 minutes instead of 15 minutes
to maximize the ultimate amount of ligated material.
(ii) The use of additional PCR cycles at the pre-hybridization
step (Figure 1, step 6) to obtain the DNA amount (250 ng)
required for hybridization.
(iii) Utilization of the entire DNA template at both the pre-
hybridization and the post-hybridization PCR steps
(Figure 1, steps 6 and 9).
Finally, to achieve the third goal which was to minimize the
amount of DNA required for hybridization and flowcell
preparation, we included the following modifications:
(i) The use of 250 ng of PCR product in the hybridization step
rather than 500 ng. On average 250 ng DNA is equivalent to
9.26610116250 bp DNA fragments, which constitutes
roughly 76,000 exomes.
(ii) In the preparation of flowcells, we varied the volume of
10 mM Tris-Cl, pH 8.5 used during the denaturation step to
Whole Exome Resequencing from Nanograms of DNA
PLoS ONE | www.plosone.org 4 March 2012 | Volume 7 | Issue 3 | e32617
enable larger volume of DNA to be used. This allowed us to
reduce the amount of DNA required for efficient cluster
generation from 10.0 nM to 1.0 nM.
In addition, to assess the success of each DNA modification, we
used the Bioanalyzer DNA High Sensitivity assay (Agilent
Technologies, Santa Clara, CA) rather than the more commonly
utilized DNA 1000 assay (Agilent Technologies). The DNA 1000
assay uses, on average, 20 times more DNA than the High
Sensitivity assay. We also included two additional quality control
visualization steps. Firstly, we visualized samples immediately post-
fragmentation to assess the efficiency of fragmentation (the
percentage of the starting material sheared to the required size
and the percentage loss of starting material). When fragmentation
was unsuccessful, high molecular weight DNA fragments were
carried through the sample preparation procedure. This reduced
the sequencing quality by increasing the range of DNA fragment
sizes in the final sequencing libraries.
Secondly, we used the High Sensitivity assay prior to ligation
(Figure 1, step 5) to measure the amount of A-tailed sample and
thus calculate the adapter volume to use to maintain 20:1 (adapter:
sample ratio during ligation). The latter ratio allowed us to
simultaneously maximize our yield of fully ligated templates and
minimize adapter dimers contamination.
Benchmarking MSA-Cap sequencing libraries
To assess the quality of sequencing libraries generated with the
MSA-Cap method we compared DNA sequence data generated
from MSA-Cap libraries using 50 ng starting material, to those
generated by the standard amount (SA) exon capture procedure
using 3 mg starting DNA. We used three different sets of samples:
(i) genomic DNA from a female HapMap sample (NA12813) for
which single nucleotide variants (SNVs) had previously been
identified [8], (ii) genomic DNA from a plasma cell leukaemia
(PCL) tumour sample with known copy number variation (CNV)
and SNV status, and (iii) normal (non-tumour) DNA from the
same individual as in (ii), derived from a buccal swab. All samples
were sequenced using 2676 bp paired-end runs that in each case
resulted in ,9 Gb raw yield per library (Table S1). Initial
inspection of the Intensity Versus Cycle (IVC) plots as well as the
summary statistics produced by the Illumina pipeline revealed
comparable metrics for all the libraries in terms of mappable yield,
insert size, percent purity filtered reads and percent aligned reads
(Table S1).
So as to compare the quality of SA libraries and MSA-Cap
libraries, we compared sequencing data in terms of the frequency
of reads mapped to the reference genome, the median depth of
sequencing reads across the genome, and finally the coverage of
sequencing data.
The frequency of reads mapped to the genome (% reads
mapped) was similar for SA and MSA-Cap samples, irrespective of
the sample type (Table 1). The median depth of coverage for the
three sample sets (PCL-tumour, PCL-buccal swab and NA12813)
in which MSA-Cap sample preparation was compared to SA was
between 68 and 106 (Table 1). Regardless of difference in
coverage between the different samples the percentage bases
covered at least by one read (coverage at $16) was similar for all
samples and libraries (between 97% and 99%, Table 1). When
coverage $206 was taken into account (usually required for
reliable SNV calling), the percentage coverage was marginally
lower for the PCL MSA-Cap libraries than for their respective SA
libraries (Table 1, 3–4% lower) although this could be compen-
sated by increasing sequencing depth.
We found the capture efficiency using Agilent SureSelect
Human All Exon kit version 1 to be dependent upon the GC-
content of the targeted region, with regions of GC-content
between 30% and 50% being preferentially captured and regions
with GC-content above 70% having minimal representation in the
final sequencing library (Figure 2). This GC-bias likely contributes
to the non-uniformity of coverage and could explain the absence
of some targeted GC-rich regions in the final datasets. However,
we did not observe any difference in the GC-bias between SA- and
MSA-Cap samples (Figure 2).
Another parameter that defines the success of whole exome
capture and sequencing is library complexity, i.e. the percentage of
reads that following mapping are found to have unique start sites.
Low library complexity can result in exomic regions being absent
from the final sequencing libraries and that unable to be used for
data generation. The percentage of reads with unique start sites
was marginally lower for all MSA-Cap libraries: 89% in MSA-Cap
vs. 96% in SA for PCL-buccal swab, 83% in MSA-Cap vs. 91% in
SA for PCL-tumour and 78% in MSA-Cap vs. 86% in SA for
NA12813 (Table 1). Importantly, the decrease in number of reads
with unique starts did not affect the capture specificity (percentage
of reads that map on target) in MSA-Cap libraries. We found the
latter parameter to be between 55–60% for all samples (Table 1).
Finally, the MSA-Cap library preparation method compared
favourably to the standard (SA) method in respect to time required
for sample preparation and the cost of sample preparation. In fact
because of the replacement of SPRI bead purification with Zymo
column steps and the removal of one additional purification step,
the MSA-Cap sample preparation procedure was actually shorter
by two hours than the standard procedure (Methods S1, Appendix
3). The cost of the MSA-Cap sample preparation was marginally
higher (2%) than that of the SA library preparation.
Table 1. Target enrichment and sequencing quality metrics.
PCL-tumour DNA PCL-buccal Swab DNA NA12813 DNA
SA MSA-Cap SA MSA-Cap SA MSA-Cap
% Reads mapped 90% 92% 93% 95% 90% 93%
Median depth of coverage 98 98 106 94 68 76
Coverage ($16) 98% 97% 99% 99% 97% 99%
Coverage ($206) 88% 84% 92% 88% 79% 87%
% Unique reads 96% 89% 91% 83% 86% 78%
% Reads on target 56% 55% 60% 60% 57% 57%
doi:10.1371/journal.pone.0032617.t001
Whole Exome Resequencing from Nanograms of DNA
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Genotype calling from MSA-Cap libraries
One of the major uses of DNA sequencing is the identification
of genetic mutations. In order to assess the validity of MSA-Cap
libraries we investigated the concordance between SNP calls
made from deep sequenced MSA-Cap libraries with those
made using an orthogonal technology, Affymetrix SNP6 DNA
arrays.
Using an analysis of SNP calls in a PCL-tumour sample and a
HapMap sample, we found MSA-Cap libraries to give highly
concordant (.96%) SNP calls when compared to SNP6 genotypes
(Table 2). The extent of agreement between MSA-Cap library
SNP calls and corresponding SNP6 genotypes was also similar
when SA libraries were used.
Comparison of genome-wide variants identified by deep
sequencing
In addition to the comparison with SNP6 genotypes, we
examined the quality of MSA-Cap libraries by assessing the
similarity in mutational spectrum between MSA-Cap and SA
libraries derived from the same genomic DNA sample. Here we
used the GATK to call variants in a normal and tumour sample
from a PCL patient. As shown in Figure 3, the mutational
spectrum was very similar in all libraries, suggesting that MSA-
Cap can deliver mutational data similar to the standard method of
exome capture and resequencing.
As part of this analysis, we also generated copy number profiles
for a cancer genome from each library and compared these to
Figure 2. Capture efficiency of probes with different GC-content (percentage of GC bases from the total bases) for SA and MSA-Cap
HapMap (NA12813) libraries. The efficiency is shown as median depth of coverage of probe regions with different GC percentage. The GC
percentage range of the probes is shown on the x axis. The median depth of coverage for the probes in the HapMap sample, either SA or MSA-Cap
libraries, is represented on the left y axis. The percentage of probes in each GC content is shown on the right y axis.
doi:10.1371/journal.pone.0032617.g002
Table 2. Genotype concordance for SNP calls in a PCL-tumour sample and a HapMap (NA12813) sample.
PCL-tumour NA12813
Method of preparation SA MSA-Cap SA MSA-Cap
% Known SNPs miscalled by deep sequencing 5% 4% 6% 5%
% Known SNPs not called by deep sequencing 0% 0% 4% 1%
% Homozygous variants called as heterozygous by deep sequencing 4% 3% 2% 2%
Total SNP concordance of deep sequencing data with SNP6 array data 99% 99% 93% 96%
For the PCL-tumour sample, the variants called by deep sequencing were compared to data from Affymetrix SNP 6.0 DNA array while for the HapMap sample published
data were used for the comparison.
doi:10.1371/journal.pone.0032617.t002
Whole Exome Resequencing from Nanograms of DNA
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each other as well as to the known copy number aberrations in the
sample identified by Affymetrix DNA SNP6 array. The copy
number profile from the MSA-Cap library compared favourably
to the profile generated from the SA library (Figure 4) with the
deletions in 6q, 12p, 13q, 17p and the gain in 6p clearly
distinguishable.
Figure 3. Mutational spectrum from SA and MSA-Cap libraries, prepared from PCL-tumour or PCL-buccal swab samples. Non-filtered
variants were identified in each sample using Broad Institute Best Practice pipeline version 1.0.5273 upon comparison to human hg19 reference
sequence and categorized according to putative gene effect. The cumulative number of variants for each library type is shown on the x axis and the
sample and library type on the y axis. Variant categories, as assigned by the Ensembl database, are on the right side of the figure.
doi:10.1371/journal.pone.0032617.g003
Figure 4. Copy number profiles estimated by deep sequencing of PCL-tumour samples, prepared using the SA- or MSA-Cap
methods. Chromosomes 1 to 22 plus X and Y are shown on the x axis. The log2 ratio of the normalized by the normal depth values for the PCL-
tumour libraries is represented on the y axis. Arrows point towards the detected by deep sequencing and previously identified by SNP6 array copy
number changes: gain (6p), del (6q), del (12p), del (13q) and del (17p).
doi:10.1371/journal.pone.0032617.g004
Whole Exome Resequencing from Nanograms of DNA
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Discussion
The goal of this study was to develop a simple target enrichment
protocol that could be used on DNA templates of less than 1 mg.
Our method and the subsequent analysis of MSA-Cap libraries
suggest that this is possible and that as little as 50 ng of DNA may
be used as the starting amount. Given the limited amount of DNA
often recovered from small samples (such as fine needle aspirates,
for example), it is possible that this method will find considerable
utility. Moreover, by using the Agilent Sure Select system as a basis
for our adapted protocol, the reagents needed to perform MSA-
Cap are widely available and the method useable by any
laboratory. In our facility, the MSA-Cap library preparation
method has also been used to prepare sequencing libraries from 44
clinical (tumour-matched normal multiple myeloma) samples
(Walker et al., in preparation). The quality of the libraries
obtained was consistent with the results presented in this study
(Walker et al., in preparation).
Our protocol and the accompanying analysis provide a number
of benefits when compared to other submicrogram DNA-based
whole exome protocols. An alternative system, the transposon-
based whole exome capture protocol (7), also uses 50 ng of starting
DNA material. However, the enrichment and sequencing
parameters described by Adey and colleagues [7] were as follows:
78% reads mapping, 47% of which on-target and 87% coverage
$16. These results did not compare favourably to our method, in
which the percentage of reads mapping was over 14% higher,
whilst the average coverage at 16 depth was 98% (Table 1).
Importantly, the study of Adey and colleagues (7) did not examine
variant concordance levels between deep sequencing and an
orthogonal technology such as SNP arrays. Thus, it remains
uncertain whether the transposon-based whole exome capture
method can effectively deliver high-quality variant analysis.
In conclusion, MSA-Cap provides a straightforward method for
the capture of exomic DNA (and potentially other targeted
regions) in situations when template DNA is in short supply. As we
have shown with the SNPs/indels and CNVs identification in
matched tumour and normal sample pairs, one particular utility of
this method will be in the analysis of tumour samples. We also note
that the ability of our method to deliver reliable variant calls from
50 ng of starting DNA will also allow the exomic resequencing of
multiple different microdissected fractions from the same tumour,
and thus an increasing understanding of intra-tumoural genetic
heterogeneity [15].
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loaded. 2.04 ng/ml or 1.69 ng/ml were recovered using Zymo
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